Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer
about
Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic ApplicationsDo the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?Re-configuration of sphingolipid metabolism by oncogenic transformation.Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomainsNeutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptorsStructure, biological functions and applications of the AB5 toxins.Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells.Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor developmentHuman breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.Shiga toxins induce autophagy leading to differential signalling pathways in toxin-sensitive and toxin-resistant human cells.A Topographical Atlas of Shiga Toxin 2e Receptor Distribution in the Tissues of Weaned PigletsAssociation of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells.Globoside promotes activation of ERK by interaction with the epidermal growth factor receptorRole of Verocytotoxigenic Escherichia Coli in the Swine Production ChainLipidomics of glycosphingolipids.Protein toxins from plants and bacteria: probes for intracellular transport and tools in medicine.Shiga toxin and its use in targeted cancer therapy and imagingImmunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy.The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety?Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistanceShiga toxin 1, as DNA repair inhibitor, synergistically potentiates the activity of the anticancer drug, mafosfamide, on raji cells.Fabry disease and incidence of cancerShiga Toxin Glycosphingolipid Receptors in Human Caco-2 and HCT-8 Colon Epithelial Cell Lines.Shiga toxin glycosphingolipid receptors and their lipid membrane ensemble in primary human blood-brain barrier endothelial cells.Biological Roles of Aberrantly Expressed Glycosphingolipids and Related Enzymes in Human Cancer Development and Progression.Biochemical, pathological and oncological relevance of Gb3Cer receptor
P2860
Q26752966-C61FEF4E-4062-428E-8C55-CE43E723A1DDQ26858938-D59C1B37-3D5A-4618-B437-F0573C1C4D81Q33649823-183C2A78-6883-4211-9876-9E619D4A7B8DQ33767713-A3D1D445-C7BA-415D-9C46-72BA385C5EB3Q33798933-EBDC3858-82D2-4CE7-9B1E-A7DF4A2A1707Q33993186-3D5C60F3-0A7C-44B3-9F99-3721F063E6AEQ34102115-C3811728-591E-4760-AA69-7A5D9DB74574Q34323763-53538C2B-01DB-40D9-B811-E9790AA4EF67Q34493644-382223E2-F415-4891-A1AE-6AFBFFA308E8Q34897367-EE7B0183-4C41-4E6E-B892-8E5226BFB960Q35174495-8C1F3F70-B90D-4D13-8376-8951F6D58BBDQ35214193-D024864E-41E6-4685-9228-F9522A056C59Q36213004-50ABE79E-C2CD-4747-BE91-D40D5D830338Q36744101-D105EAFF-1E23-4805-8385-F983F8EA6EC9Q36821175-AAE0F8F9-74B8-42A7-AD55-178EE71614EAQ37361299-A9B271E3-3133-4120-9FAE-8644D88746F3Q37512584-ECF2F127-7EE7-4F71-AC57-A5355F15C7C5Q37729388-73160FF6-1EB6-4A33-A069-F9C7691B1481Q37831422-B834A8C6-BF61-40B9-8E16-03173C6DC641Q37974938-857384AC-AD23-471B-8B24-F9D766450F78Q38022246-17B16032-5DAE-4B7B-A183-2E27A862464AQ38024274-FF44A447-187C-4BD9-9302-595F5EB9D2C7Q38195691-026C10A2-06F1-410A-9C8B-7B13EE33BFF1Q39190558-F113D43E-D310-41E9-BE0F-F63ACC698A96Q41594471-0E2ABA4E-E416-479F-951A-B4EE1EC70E5FQ47121042-0C2651DE-C6E5-4A77-8030-3D9A40E487B1Q48553736-905871C4-D0AA-4D9D-BA57-5E5DD350372FQ54943815-F5083130-38C2-48AD-8DE4-BFBFDA3F8DF3Q57117659-4849F5CC-B9C9-42B8-A3BE-093C2A7A26FC
P2860
Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@ast
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@en
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@en-gb
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@nl
type
label
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@ast
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@en
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@en-gb
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@nl
prefLabel
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@ast
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@en
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@en-gb
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@nl
P2093
P2860
P50
P1433
P1476
Shiga toxin receptor Gb3Cer/CD ...... t in pancreas and colon cancer
@en
P2093
Alexander W Friedrich
Irena Drmić-Hofman
Jamal Souady
Jörg Haier
M Alexander Schmidt
Norbert Senninger
Stefan Berkenkamp
P2860
P356
10.1371/JOURNAL.PONE.0006813
P407
P577
2009-01-01T00:00:00Z